Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogen...

FDA Device Recall #Z-1921-2016 — Class II — March 24, 2016

Recall Summary

Recall Number Z-1921-2016
Classification Class II — Moderate risk
Date Initiated March 24, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Remel Inc
Location Lenexa, KS
Product Type Devices
Quantity 2 units were imported and distributed domestically

Product Description

Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic

Reason for Recall

Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.

Distribution Pattern

US distribution in MO.

Lot / Code Information

Lot 1717357 Exp: 31Aug2017

Other Recalls from Remel Inc

Recall # Classification Product Date
Z-0331-2023 Class I Thermo SCIENTIFIC, Sensititre CMC5VGNF, Gram Ne... Oct 20, 2022
Z-0334-2023 Class I Thermo SCIENTIFIC, Sensititre STP6F, Gram Negat... Oct 20, 2022
Z-0330-2023 Class I Thermo SCIENTIFIC, Sensititre HPB1, Gram Negati... Oct 20, 2022
Z-0329-2023 Class I Thermo SCIENTIFIC, Sensititre GN7F, Gram Negati... Oct 20, 2022
Z-0327-2023 Class I Thermo SCIENTIFIC Sensititre Plate, GN4F, Gram ... Oct 20, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.